NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Orange Grove Bio

Orange Grove Bio

Private
Cincinnati, OhioHealthcare & Life Scienceshttps://www.orangegrovebio.com

Last Round

VC Round

Aug 12, 2025

Total Funding Raised

$2.05M

Company Overview

Orange Grove Bio is a biopharmaceutical company focused on a preclinical drug investment and development platform that aims to reduce drug discovery costs and expedite the advancement of therapies into clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotech venture creationbiotech venture studiopreclinical drug developmenttherapeutic asset licensingdrug discoveryacademic spin-outsbiotech company buildertech transferoncology therapeuticsautoimmune disease therapeuticslife science investinginflammatory disease therapeuticsbiotech incubatoruniversity partnershipspreclinical assets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orange Grove Bio Comparables

Compare Orange Grove Bio with similar companies based on industry and business-model similarity.

Orange Grove Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apollo Therapeutics
81%
Evotec
76%
Alexandria Real Estate Equities
42%

Orange Grove Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 12, 2025
GrantSep 28, 2023
VC RoundAug 25, 2022

Key People

Founding team and executive leadership

Salvatore Cremona

Chief Executive Officer

Executive Team

David Crampton

Chief Financial Officer

Executive Team

Orange Grove Bio Investors

Notable investors and investment history

Orange Grove Bio investors
InvestorRounds
AlleyCorpVC Round
Catalytic Impact FoundationVC Round

Orange Grove Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orange Grove Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orange Grove Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCincinnati, Ohio
Employee Range28
Year Founded2019
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.